Comparison of Pain Relief After Upper and Lower Lumbar Erector Spinae Plane Block

Pain, Chronic Clinical Trial

Official title:

Comparison of Pain Relief and Spread Level in Upper and Lower Lumbar Erector Spinae Plane Block

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05487339
• Other study ID #: Keimyung Medical School
• Status: Completed
• Phase: N/A
• Start date: August 12, 2022
• Est. completion date: February 24, 2023

Study information

• Verified date: February 2023
• Source: Keimyung University Dongsan Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary endpoint of this study was to identify if eretor spinae plane block (ESPB) has any effect in relieving low back pain or leg pain in lumbar radiculopathy. The secondary endpoint was to compare the number of spread level when upper or lower lumbar ESPB was performed.

Description:

The erector spinae plane block (ESPB) is a less invasive, safer, and technically easy alternative procedure to conventional neuraxial anesthetic techniques. In contrast to common neuraxial techniques such as paravertebral and epidural injections, the ESPB targets an interfascial plane which is far from the spinal cord, root, and pleura. First applied to thoracic neuropathic pain, currently ESPB is being applied to postoperative pain control and includes variable clinical situations. In the abdomen and thoracic wall, thoracic ESPB can be applied for pain control after cardiac surgery, video-assisted thoracic surgery, laparoscopic cholecystectomy, and thoracotomy. Recently, favorable postoperative pain control after lumbar spinal or lower limb surgeries has been reported with lumbar ESPB. In addition, ESPB has also been used for chronic pain conditions in the upper and lower extremities. To investigate the possible mechanism of action of the ESPB, many previous studies have focused on examining the physical spread of the injected agent. Commonly, contrast dye injections in human cadavers have been utilized to assess the spread level. Physical spread level was determined using various methods including direct dissection or sectioning, computed tomography (CT), thoracoscopic inspection, or magnetic resonance imaging (MRI) with radiocontrast injection. Apart from human cadaver studies, physical spread level has been evaluated in alive patients using a variable volume of local anesthetics mixed with radiocontrast. However, these studies are limited by the small number of included patients. Therefore, the exact spread level of injected local anesthetics remains unclear and a study on a large number of patients is still required

Recruitment information / eligibility

• Status: Completed
• Enrollment: 84
• Est. completion date: February 24, 2023
• Est. primary completion date: February 24, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

• lumbar disc herniation

• lumbar foraminal stenosis

• lumbar central stenosis

• lumbar spondylolisthesis

• severe level of spine at L3-4

• numerical rating scale > 4

• back pain functional scale < 45

• duration of pain > 1 month

• patients who can fully understand all items described in BPFS

Exclusion Criteria:

• Allergy to local anesthetics or contrast medium

• Pregnancy

• Spine deformity

• Prior history of lumbar spine surgery

• No previous lumbar MRI or CT

• Patients with coagulation abnormality

• Incorrect level of ESPB

Related Conditions & MeSH terms

• Chronic Pain
• Pain, Chronic

Intervention

Procedure:
• Erector spinae plane block
fascial plane injection guided by fluoroscopy device

Locations

Country	Name	City	State
Korea, Republic of	Hong ji HEE	Daegu

Sponsors (1)

Lead Sponsor	Collaborator
Keimyung University Dongsan Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Numerical rating scale changes among 5 times period	numerical rating scale changes after ESPB among 5 times period	baseline, 10 minutes after ESPB, 1 week after ESPB, 2 weeks after ESPB, 4 weeks after ESPB
Primary	back pain function scale changes among 2 times period	back pain function scale changes after ESPB among 2 times period	baseline, 4 weeks after ESPB
Secondary	spread level in the cranio-caudal direction	fluoroscopic contrast medium spread level in the cranio-caudal direction	baseline, 1 minute after ESPB